1AVOGARO A, VIGILI DE KREUTZ ENBERG S, NEGUT C, et al. Diabetic cardiomyopathy:a metabolic perspective [J].Am J Cardiol, 2004,93 (8A) : 13A - 16A.
2HOKK, PINSKY JL, KANNELWB, etal. The epidemiology of heart failure: the Framingham Study [J], J Am Coil Cardiol,1993,22(7) :6A - 13A.
3KITZMAN D W, GARDIN J M, GOTTDIENER J S, et al. Cardiovascular Health Study Research Group. Importance of heart failure with preserved systolic function in patients > or =65 years of age. CHS Research Group. Cardiovascular Health Study [J]. Am J Cardiol, 2001,87 (4):413 -419.
4MCMURRAY J J, STEWART S. Epidemiology, aetiology and prognosis of heart failure [J] . Heart, 2000, 83(5): 596-602.
5BERTONI A G, TSAI A, KASPER E K, et al. Diabetes and idiopathic cardiomyopathy: a nationwide case-control study [J].Diabetes Care, 2003, 26(10): 2791-2795.
6BIRNBAUM M J. Turning down insulin signaling [J]. J Clin Invest,2001,108(5) :655 - 659.
7KIM J K, KIM Y J, FILLMORE J J, et al.Prevention of fat-induced insulin resistance by salieylate [J]. J Clin Invest, 2001,108(3) : 437 - 446.
8BRAZIL D P, HEMMINGS B A. Ten years of protein kinase B signalling: a hard Akt to follow [J]. Trends Biochem Sci, 2001,26( 11 ) :657 - 664.
9MORISCO C, ZEBROWSKI D,CONDORELLI G, et al. The Akt-glycogen synthase kinase 3beta pathway regulates transcription of atrial natriuretic factor induced by beta-adrenergic receptor stimulation in cardiac myocytes [J]. J Biol Chem,2000,275 (19) : 14466 - 14475.
10SCHWARTZBAUER G, ROBBINS J. The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival [J]. J Biol Chem,2001,276 (43) : 35786 - 35793.
